|
C16ORF88 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07867056900568E-12 |
| Normal-vs-Stage2 |
1.355080E-04 |
| Normal-vs-Stage3 |
1.5552099999927E-05 |
| Normal-vs-Stage4 |
4.415900E-03 |
| Stage1-vs-Stage2 |
7.009400E-01 |
| Stage1-vs-Stage3 |
1.790180E-01 |
| Stage1-vs-Stage4 |
6.199800E-01 |
| Stage2-vs-Stage3 |
2.182800E-01 |
| Stage2-vs-Stage4 |
4.483400E-01 |
| Stage3-vs-Stage4 |
7.493800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.81730000124037E-08 |
| Normal-vs-Asian |
3.678100E-02 |
| Caucasian-vs-AfricanAmerican |
6.808600E-04 |
| Caucasian-vs-Asian |
9.805000E-01 |
| AfricanAmerican-vs-Asian |
1.948580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.10862446895044E-15 |
| Normal-vs-Female |
1.53588253226644E-12 |
| Male-vs-Female |
4.072000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.54660000029061E-07 |
| Normal-vs-Extreme_Weight |
1.63020041910045E-10 |
| Normal-vs-Obese |
3.20680038079502E-10 |
| Normal-vs-Extreme_Obese |
1.109360E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.484000E-01 |
| Normal_Weight-vs-Obese |
1.054160E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.229600E-01 |
| Extreme_Weight-vs-Obese |
1.428570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.493800E-01 |
| Obese-vs-Extreme_Obese |
1.112010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.57289999997068E-06 |
| Normal-vs-Age(41-60Yrs) |
1.63191682389652E-12 |
| Normal-vs-Age(61-80Yrs) |
7.00217661631086E-13 |
| Normal-vs-Age(81-100Yrs) |
2.082100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.981970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.112640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.836900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.065000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.224500E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.904000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.62700000000604E-05 |
| Normal-VS-KIRP CIMP |
2.445000E-04 |
| Normal-VS-Unclassified PRCC |
5.94650000018682E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.935200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.329600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.264400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.255700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.837800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.338600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.29989999992009E-07 |
| Normal-vs-N1 |
9.96229999999931E-05 |
| Normal-vs-N2 |
1.269230E-01 |
| N0-vs-N1 |
6.783900E-02 |
| N0-vs-N2 |
1.916970E-01 |
| N1-vs-N2 |
9.789400E-01 |
|
|
